Gene therapy - Phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II-IV with a single intratumoral injection of hIL-2 plasmids formulated in DOTMA/Chol

B. Wollenberg*, Kastenbauer, H. Mundl, J. Schaumberg, Anna Mayer, Michaela Andratschke, Stephan Lang, Christof Pauli, Reinhard Zeidler, Stephan Ihrler, Löhrs, Kurt Naujoks, Rob Rollston

*Corresponding author for this work
26 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Gene therapy - Phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II-IV with a single intratumoral injection of hIL-2 plasmids formulated in DOTMA/Chol'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology